Sugi Predict

Sugi Predict / Compounds / SCHEMBL10114563

SCHEMBL10114563

SCHEMBL10114563

CC(C)(C)S(=O)(=O)NC1CCC(C(=O)Nc2ccc(-c3ccno3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.53
▸ POLB P06746 1/20 0.41
▸ NAMPT P43490 1/20 0.40
▸ PTPN1 P18031 2/20 0.40
▸ PTPN2 P17706 1/20 0.39
▸ PTPN6 P29350 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TOP1 P11387 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ MDM2 Q00987 1/20 0.38
▸ ULK1 O75385 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.38
▸ KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14424255 1.00 NPY5R (0.53) NPY5RPOLBNAMPTPTPN1PTPN2
SCHEMBL14424391 0.85 KMT2A (0.42) NAMPTPTPN1NPC1RAB9ALMNA
SCHEMBL10114922 0.85 KMT2A (0.42) NAMPTPTPN1NPC1RAB9ALMNA
SCHEMBL10115773 0.84 LMNA (0.44) NPY5RPOLBLMNATOP1MEN1
SCHEMBL10114591 0.82 NPY5R (0.52) NPY5RNPC1RAB9ALMNAMEN1
SCHEMBL14424346 0.82 NPY5R (0.52) NPY5RNPC1RAB9ALMNAMEN1
SCHEMBL14424256 0.82 NPY5R (0.48) NPY5RPOLBNAMPTPTPN1PTPN2
SCHEMBL10114560 0.82 NPY5R (0.48) NPY5RPOLBNAMPTPTPN1PTPN2
SCHEMBL10114466 0.81 NPY5R (0.54) NPY5RNAMPTPTPN1PTPN2PTPN6
SCHEMBL13203763 0.81 NPY5R (0.54) NPY5RNAMPTPTPN1PTPN2PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R NPY5R 1/4885POLB 4727/4885NAMPT 2678/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R NPY5R 1/4885POLB 4751/4885NAMPT 2350/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R NPY5R 1/4885POLB 4721/4885NAMPT 2832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.